The Global Ablation Devices Market to Surge at a

New York, USA, Oct. 04, 2022 (GLOBE NEWSWIRE) — The Global Ablation Devices Market to Surge at a Significant CAGR of 11.65% by 2027 | DelveInsight

The global ablation devices market is anticipated to show positive growth owing to the factors such as the rising incidence of cancers such as liver cancer, the increasing prevalence of chronic pains such as musculoskeletal pains, the rising prevalence of cardiac arrhythmias such as atrial fibrillation, and the rising regulatory approvals for technologically advanced ablation devices.

DelveInsight’s Ablation Devices Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, ablation devices market drivers, barriers, and trends, and key ablation devices companies in the market. 

Key Takeaways from the Ablation Devices Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global ablation devices market during the forecast period. 
• Notable ablation devices companies such as Medtronic, AngioDynamics, ATRICURE INC, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, OLYMPUS CORPORATION, Ethicon (Johnson & Johnson Services, Inc), Abbott, CONMED Corporation, Smith & Nephew, BD, Varian Medical Systems Inc, Hologic Inc, Stryker, Japan Lifeline Co Ltd, Merit Medical Systems, Integra LifeSciences, Terumo Europe NV, and several others are currently operating in the ablation devices market.
• In December 2021, BD, the largest global medical technology company, announced that it had acquired Venclose, a medical technology company and its solutions for treating chronic venous insufficiency (CVI), such as radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain
• In July 2020, Ethicon, a part of the Johnson & Johnson Medical Devices Company, announced FDA had granted Breakthrough Device Designation for transbronchial microwave ablation…